Not just ACL. Progesterone recently flunked its Phase 3 TBI trials despite showing modest positive effects on mortality rates and function outcomes in earlier Phase 2 trials. results.
http://www.medpagetoday.com/Neurology/HeadTrauma/49157
- Forums
- ASX - By Stock
- A possibility worth worth contemplating
Not just ACL. Progesterone recently flunked its Phase 3 TBI...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.82 |
Change
0.210(1.35%) |
Mkt cap ! $1.995B |
Open | High | Low | Value | Volume |
$15.83 | $15.86 | $15.76 | $326.8K | 20.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 101 | $15.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.85 | 89 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 120 | 15.800 |
5 | 392 | 15.790 |
6 | 456 | 15.780 |
7 | 984 | 15.770 |
5 | 440 | 15.760 |
Price($) | Vol. | No. |
---|---|---|
15.840 | 38 | 2 |
15.850 | 341 | 3 |
15.860 | 476 | 5 |
15.870 | 376 | 4 |
15.880 | 324 | 4 |
Last trade - 10.08am 16/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online